Slowing the progression of aortic stenosis

被引：2
作者：
Maganti K. [1 ]
Rajamannan N. [1 ]
机构：
[1] Northwestern University Feinberg School of Medicine, Chicago, IL 60611
来源：
Current Treatment Options in Cardiovascular Medicine | 2008年 / 10卷 / 1期
关键词：
Aortic Valve; Aortic Stenosis; Infective Endocarditis; Rosuvastatin; Aortic Valve Replacement;
D O I：
10.1007/s11936-008-0003-3
中图分类号：
学科分类号：
摘要：
Aortic stenosis (AS) is the most frequent valvular heart disease in the Western world. The only definitive treatment for this disorder is surgical replacement of the aortic valve. Recent histopathologic studies have provided important insights into the pathogenesis of calcific AS. These results suggest that this disease develops as the result of an active disease process at the cellular and molecular levels that shares many similarities with vascular atherosclerosis, ranging from endothelial dysfunction to, ultimately, calcification. In this review, we discuss the cellular and molecular mechanisms, natural history, diagnosis, and therapeutic options, including the potential for medical therapies, for the treatment of AS. Copyright © 2008 by Current Medicine Group LLC.
引用
收藏
页码：18 / 26
页数：8
相关论文
共 60 条
[1]  
Rajamannan N.M., Bonow R.O., Rahimtoola S.H., Calcific aortic stenosis: An update, Nat Clin Pract Cardiovasc Med, 4, pp. 254-262, (2007)
[2]  
Lindroos M., Kupari M., Heikkila J., Tilvis R., Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample, J Am Coll Cardiol, 21, pp. 1220-1225, (1993)
[3]  
Roberts W.C., Ko J.M., Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation, Circulation, 111, pp. 920-925, (2005)
[4]  
Ross Jr J., Braunwald E., Aortic stenosis, Circulation, 38, pp. 61-67, (1968)
[5]  
Horstkotte D., Loogen F., The natural history of aortic valve stenosis, Eur Heart J, 9, SUPPL. E, pp. 57-64, (1988)
[6]  
Pellikka P.A., Nishimura R.A., Bailey K.R., Tajik A.J., The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis, J Am Coll Cardiol, 15, pp. 1012-1017, (1990)
[7]  
Stewart B.F., Siscovick D., Lind B.K., Et al., Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study, J Am Coll Cardiol, 29, pp. 630-634, (1997)
[8]  
Galante A., Pietroiusti A., Vellini M., Et al., C-reactive protein is increased in patients with degenerative aortic valvular stenosis, J Am Coll Cardiol, 38, pp. 1078-1082, (2001)
[9]  
Palta S., Pai A.M., Gill K.S., Pai R.G., New insights into the progression of aortic stenosis: Implications for secondary prevention, Circulation, 101, pp. 2497-2502, (2000)
[10]  
Rajamannan N.M., Edwards W.D., Spelsberg T.C., Hypercholesterolemic aortic-valve disease, N Engl J Med, 349, pp. 717-718, (2003)
123456